Matt Mockler

Matt Mockler is an experienced professional in the field of clinical operations, having held the position of Director Clinical Operations at multiple organizations, including Lantheus, Verastem Oncology, Imbria Pharmaceuticals, and Syntimmune, the latter of which was acquired by Alexion Pharmaceuticals. Additionally, Matt served as Associate Director Clinical Operations at Radius Health, Inc. Matt's educational background includes studies at The University of Kansas.